Showing results (101-110 of 196) with videos related to
Sort By:
Pageof 20
BMC Pharmacology|June 17, 2008
Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compoundsJohn C Boik, Robert A NewmanBMC Pharmacology|June 3, 2008
Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell lineStephanie K Bopp, Teresa LettieriBMC Pharmacology|April 6, 2012
Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitorAiying Wang, Charles Dorso, Lisa Kopcho, et al.BMC Pharmacology|May 31, 2012
The orthosteric agonist 2-chloro-5-hydroxyphenylglycine activates mGluR5 and mGluR1 with similar efficacy and potencyPaul J KammermeierBMC Pharmacology|May 8, 2012
5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involvedRobert Patrick Davis, Jill Pattison, Janice M Thompson, et al.BMC Pharmacology|April 3, 2002
An MCASE approach to the search of a cure for Parkinson's DiseaseGilles Klopman, Aleksandr SedykhBMC Pharmacology|March 19, 2002
Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinasesH Kenneth Kramer, Irma Onoprishvili, Matthew L Andria, et al.BMC Pharmacology|October 29, 2009
An efficient drug delivery vehicle for botulism countermeasurePeng Zhang, Radharaman Ray, Bal Ram Singh, et al.BMC Pharmacology|December 2, 2009
Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathwayDesheng Lu, Dennis A CarsonBMC Pharmacology|December 30, 2009
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptorsJan Jakubík, Alena Randáková, Esam E El-Fakahany, et al.Pageof 20